実績

2022.05.24

Inomata T, Sung J. Changing Medical Paradigm on Inflammatory Eye Disease: Technology and Its Implications for P4 Medicine. J Clin Med. 2022 May 24;11(11):2964.

2022.05.19

Lu Y, Wu Y, Zhou X, Inomata T, Gu L, Jin X, Hong J. Editorial: Advances in the Pathophysiology, Diagnosis, and Treatment of Dry Eye Disease. Front Med (Lausanne). 2022 May 19;9:925876. doi: 10.3389/fmed.2022.925876.

2022.05.01

Adachi T, Ogawa Y, Fukushi T, Ito K, Koizumi A, Shirabe M, Toriya M, Hirako J, Inomata T, Masaki K, Sasano R, Sato S, Kainuma K, Futamura M, Kan-O K, Kurashima Y, Nakajima S, Sakashita M, Morita H, Iwamoto A, Nishima S, Tamari M, Iizuka H. Research impact analysis of international funding agencies in the realm of allergy and immunology. Allergy. 2022 May;77(5):1602-1606.

2022.02.01

Rhee J, Chan TC, Chow SS, Di Zazzo A, Inomata T, Shih KC, Tong L. A Systematic Review on the Association Between Tear Film Metrics and Higher Order Aberrations in Dry Eye Disease and Treatment. Ophthalmol Ther. 2022 Feb;11(1):35-67.

2022.02.01

Zhu J, Inomata T, Shih KC, Okumura Y, Fujio K, Huang T, Nagino K, Akasaki Y, Fujimoto K, Yanagawa A, Miura M, Midorikawa-Inomata A, Hirosawa K, Kuwahara M, Shokirova H, Eguchi A, Morooka Y, Chen F, Murakami A. Application of Animal Models in Interpreting Dry Eye Disease. Front Med (Lausanne). 2022 Feb 1;9:830592.

2022.01.31

Miura M, Inomata T, Nojiri S, Sung J, Nagao M, Shimazaki J, Midorikawa-Inomata A, Okumura Y, Fujio K, Akasaki Y, Kuwahara M, Huang T, Nakamura M, Iwagami M, Hirosawa K, Fujimoto K, Murakami A. Clinical efficacy of diquafosol sodium 3% versus hyaluronic acid 0.1% in patients with dry eye disease after cataract surgery: a protocol for a single-centre, randomised controlled trial. BMJ Open. 2022 Jan 31;12(1):e052488.